Repeatability of Positron Emission Tomography (TEP) With fluorométhyl-(18F)-diméthyl-2-hydroxyéthyl-ammonium
NCT03105869 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2017-06-26
Summary
Monocentric study. Objective : Determination of the repeatability of fluorocholine PET/CT in prostate cancer
Conditions
Interventions
- DIAGNOSTIC_TEST
-
fluorocholine PET/CT
standard diagnostic PET/CT procedure
Sponsors & Collaborators
-
Poitiers University Hospital
lead OTHER
Principal Investigators
-
Catherine CHEZE LE REST · CHU Poitiers
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-12-16
- Primary Completion
- 2016-12-31
- Completion
- 2016-12-31
More Related Trials
-
Dynamic F-DOPA PET for Differential Diagnosis Between Recurrence and Radionecrosis of Brain Metastasis
NCT05762172 ·Status: COMPLETED ·Phase: NA
-
[18F]Fluoroestradiol-PET/CT Imaging of Invasive Lobular Carcinoma
NCT04252859 ·Status: TERMINATED ·Phase: PHASE2
-
Clinical Application of 68Ga-FAPI PET Imaging in Detection of Ovarian Cancer Recurrence
NCT05856409 ·Status: RECRUITING
-
Usefulness of 18F-FDG PET/CT in the Initial Staging and Surveillance of Endometrial Cancer Patients
NCT05056259 ·Status: UNKNOWN
-
18 Fluoro-deoxy-glucose Positrons Emission Tomography Combined With Computed Tomography (18-FDG TEP-CT ) in the Diagnosis of the Degeneration of Intraductal Papillary Mucinous Tumor of the Pancreas
NCT01485679 ·Status: COMPLETED ·Phase: NA
-
Semi-automated Segmentation Methods of SSTR PET for Dosimetry Prediction
NCT05537675 ·Status: COMPLETED
-
Validating Low FDG Dose PET/CT Compared to Current Standard of Care Dose PET/CT
NCT03519659 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Evaluation of Sodium Fluoride PET in the Identification of Bone Metastases in Patients Having Undergone a Choline PET for Occult Recurrence of Prostatic Adenocarcinoma
NCT02876991 ·Status: UNKNOWN ·Phase: NA
-
Prognostic Value of SPECT-CT Quantitative Indices for the Response Assessment of Bone Metastatic Prostate Carcinoma
NCT03382522 ·Status: COMPLETED
-
Interest of PET/CT at 18F-FDG in the Post-therapeutic Management of Cervical Cancer
NCT04008095 ·Status: COMPLETED
-
[Al18F]PSMA137 PET/CT Imaging for PSMA-Positive Cancer Patients
NCT04693169 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
PET and/or MRI Scans in Assessing Tumor Response in Patients Receiving Antiangiogenesis Therapy
NCT00019565 ·Status: COMPLETED ·Phase: PHASE1
-
Test-Retest Reproducibility of 18F-DCFPyL PET/CT in the Evaluation of Patients With Metastatic Prostate Cancer
NCT03793543 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of PET-CT Scanner Performances to Detect Infra-centimetric Lesions in Patients With Cancer
NCT03956459 ·Status: COMPLETED ·Phase: NA
-
Early Assessment of the Response to Neo-adjuvant Chemotherapy in Breast Cancer Patients With FDG-PET
NCT00904410 ·Status: COMPLETED ·Phase: PHASE4
-
Diagnostic Accuracy and Safety Study of FES PET/CT in Assessment of ER Status of Recurrent or Metastatic Breast Cancer
NCT01986569 ·Status: COMPLETED ·Phase: PHASE3
-
Positron Emission Tomography Imaging With [F-18] FLT Compared to [F-18] FDG in Cancer Patients for Treatment Evaluation
NCT00894101 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
18F-NaF-PET/MR vs 99mTc-MDP-SPECT/CT to Detect Bone Metastases in Prostate Cancer Patients.
NCT02969564 ·Status: COMPLETED
-
PET Imaging of Cancer Patients Using 124I-PUH71: A Pilot Study
NCT01269593 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer
NCT00935090 ·Status: RECRUITING
-
Normal Variants and Pitfalls of 18F_FDG PET/CT in Pediatric Oncology
NCT06612567 ·Status: NOT_YET_RECRUITING
-
Simultaneous Hyperpolarized [1-13C]Pyruvate and 18F-FDG PET/MRS in Cancer Patients
NCT05396118 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2
-
18F-DOPA-PET in Non-tumoral and Tumoral Brain Lesions
NCT04306484 ·Status: COMPLETED
-
Clinical Application of 18F-labeled RD2 PET/CT Imaging in the Diagnosis and Treatment of Small Liver Carcinoma
NCT05681234 ·Status: COMPLETED ·Phase: NA
-
[18F]FES PET/.CT in Uterine Cancer
NCT05916196 ·Status: RECRUITING ·Phase: PHASE2